Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
This study has been terminated.
(study terminated 12Feb09 due to low recruitment)
Sponsor:
University Health Network, Toronto
Collaborators:
Princess Margaret Hospital, Canada
Mount Sinai Hospital, Canada
Novartis
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00461929
First received: April 16, 2007
Last updated: February 12, 2009
Last verified: April 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |